SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of Kindred Biosciences, Inc. Buyout

WILMINGTON, Del., June 16, 2021 (GLOBE NEWSWIRE) -- Rigrodsky Law, P.A. announces that it is investigating Kindred Biosciences, Inc. (“Kindred”) (NASDAQ CM: KIN) regarding possible breaches of fiduciary duties and other violations of law related to Kindred’s agreement to be acquired by Elanco Animal Health Incorporated (NYSE: ELAN) and Knight Merger Sub, Inc.   Under the terms of the agreement, Kindred’s shareholders will receive $9.25 in cash per share.

To learn more about this investigation and your rights, visit:

You may also contact Seth D. Rigrodsky or Gina M. Serra cost and obligation free at (888) 969-4242 or

Rigrodsky Law, P.A., with offices in Delaware and New York, has recovered hundreds of millions of dollars on behalf of investors and achieved substantial corporate governance reforms in securities fraud and corporate class actions nationwide.

Attorney advertising.  Prior results do not guarantee a similar outcome.


Rigrodsky Law, P.A.
Seth D. Rigrodsky
Gina M. Serra
(888) 969-4242 (Toll Free)
(302) 295-5310
Fax: (302) 654-7530